Join us virtually for a unique educational experience. In this debate-style series, nationally recognized thought leaders take opposing sides on clinical, and sometimes controversial, topics currently disrupting the practice of hematology/oncology.
Through a comprehensive review of the latest clinical advancements in hematologic malignancies, robust audience engagement, and ample discussion, participants will leave equipped with practical implications and applications to put into practice immediately.
New Exclusive Session for 2021: Considerations on Next Generation Sequencing
NGS Testing Considerations Across Hematologic Malignancies
Assessing CLL with Peripheral Blood MRD?
MRD Assessment in ALL as a Correlate to Disease Outcomes?
Multiple Myeloma and MRD?